Download As defined by GEC-ESTRO, the high risk CTV (HR

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
1. As defined by GEC-ESTRO, the high risk CTV (HR-CTV)
a. is the GTV and presumed extra-cervical tumor spread
b. Includes the GTV at the time of BT plus any MRI grey zones
c. represent areas of major microscopic tumor load
d. D90 should be > 125 Gy from the sum of EBRT + BT
e. is the GTV with a 5-15mm margin
2. As defined by GEC-ESTRO, the intermediate risk CTV (IR-CTV)
a. For limited disease, is the HR-CTV plus a margin
b. For extensive disease, is the HR-CTV plus a margin
c. Is thought to represent macroscopic tumor load
d. D90 should be > 87 Gy from the sum of EBRT + BT
e. Includes any MRI grey zones
3. Implementing image guided brachytherapy using GEC-ESTRO guidelines has been shown to
a. Reduce local control for tumors < 5 cm
b. Improve local control for tumors > 5 cm
c. Increase Grade 4 treatment related GU/GI toxicity
d. Increase Pelvic Recurrence
e. Prevent the use of IMRT boosts
Answer Key:
1. B – includes the GTV at the time of brachytherapy plus any MRI grey zones. The HR CTV includes
the whole cervix and presumed extracervical spread. An MRI is performed at the time of
brachytherapy to define the GTV and MRI grey zones, which are both included in the HR CTV.
The HR CTV is thought to represent macroscopic tumor load and as such should receive doses >
85 Gy. Recent dose volume analyses have suggested a D90 HR-CTV goal of > 87 Gy.
Slides #16-18, 22 and 33.
•
References: Haie-Mader, C et al. Recommendations from Gynaecological (GYN) GEC-ESTRO
Working Group I: concepts and terms in 3D image based 3D treatment planning in cervix cancer
brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiotherapy Oncol 2005 74:
235-45 and Dimopoulos, JCA et al. Dose-effect relationshop for local control of cervical cancer
by magnetic resonanace image-guided brachytherapy. Radiotherapy and Oncology 2009
(93):311-15.
2. A – IR-CTV for limited disease is the HR-CTV plus a margin. For extensive disease, this volume is
based on the GTV at the time of diagnosis. The IR CTV is thought to represent microscopic
disease, and as such should receive 60 Gy.
Slides #16-22
Reference: Haie-Mader, C et al. Recommendations from Gynaecological (GYN) GEC-ESTRO
Working Group I: concepts and terms in 3D image based 3D treatment planning in cervix cancer
brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiotherapy Oncol 2005 74:
235-45
3. B - Improve local control for tumors > 5cm. Implementation of IGBT using GEC-ESRO guidelines
has been shown to improve local control for tumors of any size, improve overall survival for
patients and reduce toxicity.
Slides #31-32
•
References: Potter, R et al. Clinical impact of MRI assisted dose volume adaptation and dose
escalation in brachytherapy for locally advanced cervical cancer. Radiotherapy Oncol 2007
83(2): 148-55 and Potter, R et al. Clinical outcome of protocol based image (MRI) guided
adaptive brachytherapy combined with 3D conformal radiotherapy with or without
chemotherapy in patients with locally advanced cervical cancer. Radiotherapy Oncol 2011
100(1):116-23.